Patients with type 2 diabetes and a baseline HbA1c greater than 7.0% experienced greater cardiovascular benefits while using oral semaglutide. Oral semaglutide elicits more pronounced cardiovascular ...

Preserving muscle could be key to getting the full health benefits of Semaglutide. The Role of Protein in Preventing Muscle Loss One encouraging part of the study was the link between protein intake ...

"Our data strongly suggest the renal benefits of oral semaglutide in a broad population of PWT2D [people with T2D]. Given the global supply chain issues for subcutaneous GLP-1 RAs [receptor agonists], ...

A new analysis of the SELECT trial – the largest and longest clinical trial to date examining the cardiovascular benefits of semaglutide (a medication used to support weight loss and diabetes ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks among the best biotech stocks to buy. On September 17, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) revealed the findings of its Phase 2 COURAGE ...

Database study compares protective effect of new GLP-1-based drugs in cardiovascular risk patients Evident heart benefits beyond weight loss Only few differences in effectiveness between semaglutide ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...

A Danish trial found that semaglutide, a drug used for weight loss and diabetes, significantly reduced heavy drinking and overall alcohol consumption in obese adults with alcohol use disorder. Over 26 ...